Berlin, Germany

Michael Kröber

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 17.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Berlin, DE (2020 - 2021)
  • Erlin, DE (2023)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Michael Kröber: Innovator in Pharmaceutical Chemistry**

Introduction

Michael Kröber is a notable inventor located in Berlin, Germany. With a focus on pharmaceutical chemistry, he has been awarded a total of three patents. His research largely revolves around triazolone compounds, which have significant implications in treating various diseases.

Latest Patents

Among his latest patents, Michael Kröber has developed 2,4,5-trisubstituted 1,2,4-triazolones, which are useful as inhibitors of dihydroorotate dehydrogenase (DHODH). These patents detail the triazolone compounds of general formula (I), where R, R, R, R, and R are defined explicitly in his documentation. The inventions include methods for preparing these compounds, intermediate compounds useful for their synthesis, and pharmaceutical compositions for treating or preventing hyperproliferative disorders, either as a sole agent or in combination with other active ingredients.

Career Highlights

Michael Kröber has worked with esteemed organizations, including The Broad Institute, Inc. and Harvard College, where he contributed to significant advancements in pharmaceutical research. His work has greatly impacted the development and formulation of new treatments.

Collaborations

Throughout his career, Michael has collaborated with notable professionals such as Stefan Nikolaus Gradl and Duy Nguyen. These collaborations highlight his commitment to advancing innovation in the fields of chemistry and pharmaceuticals.

Conclusion

Michael Kröber's contributions to the pharmaceutical industry through his inventions and patents position him as a key figure in ongoing medical research. His ongoing work promises to enhance the understanding and treatment of hyperproliferative disorders, showcasing the potential for innovation within pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…